353
Participants
Start Date
September 28, 2021
Primary Completion Date
February 10, 2023
Study Completion Date
August 14, 2023
ARO-APOC3
ARO-APOC3 Injection
Placebo
Sterile Normal Saline (0.9% NaCl)
Research Site 11, Auckland
Research Site 19, Clayton
Research Site 30, Morayfield
Research Site 29, Adelaide
Research Site 27, Joondalup
Research Site 16, Christchurch
Research Site 17, New Windsor
Research Site 7, Greenville
Research Site 18, Dunwoody
Research Site 5, Pembroke Pines
Research Site 14, Miami Springs
Research Site 1, Fort Lauderdale
Research Site 2, Boca Raton
Research Site 4, Franklin
Research Site 12, Dayton
Research Site 6, Houston
Research Site 32, Houston
Research Site 13, San Antonio
Research Site 31, Las Vegas
Research Site 3, Beverly Hills
Research Site 8, Northridge
Research Site 15, Concord
Research Site 10, Montreal
Research Site 20, Balatonfüred
Research Site 21, Debrecen
Research Site 22, Nyíregyháza
Research Site 28, Lodz
Research Site 24, Lodz
Research Site 25, Poznan
Research Site 26, Rzeszów
Lead Sponsor
Arrowhead Pharmaceuticals
INDUSTRY